BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14240726)

  • 1. METABOLISM OF 6-MERCAPTOPURINE RIBONUCLEOSIDE BY EHRLICH ASCITES CARCINOMA CELLS.
    PATERSON AR; SUTHERLAND A
    Can J Biochem; 1964 Oct; 42():1415-23. PubMed ID: 14240726
    [No Abstract]   [Full Text] [Related]  

  • 2. INHIBITION BY 6-MERCAPTOPURINE OF PURINE PHOSPHORIBOSYLTRANSFERASES FROM EHRLICH ASCITES-TUMOUR CELLS THAT ARE RESISTANT TO THE DRUG.
    ATKINSON MR; MURRAY AW
    Biochem J; 1965 Jan; 94(1):71-4. PubMed ID: 14342251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ENHANCEMENT OF THIOINOSINATE SYNTHESIS IN THE EHRLICH ASCITES CARCINOMA BY PRIOR TREATMENT WITH 6-MERCAPTOPURINE OR AZASERINE.
    PATERSON AR
    Acta Unio Int Contra Cancrum; 1964; 20():1033-6. PubMed ID: 14274687
    [No Abstract]   [Full Text] [Related]  

  • 4. SYNTHESIS OF 5-PHOSPHORIBOSYL 1-PYROPHOSPHATE FROM RIBONUCLEOSIDES IN EHRLICH ASCITES TUMOR CELLS IN VITRO.
    HENDERSON JF; KHOO MK
    J Biol Chem; 1965 Jun; 240():2363-6. PubMed ID: 14304838
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination chemotherapy: treatment of the Ehrlich ascites carcinoma and several drug-resistant sublines with combinations of 6-mercaptopurine and 6-(methylmercapto)purine ribonucleoside.
    Paterson AR; Wang MC
    Can J Biochem; 1970 Jan; 48(1):79-83. PubMed ID: 5512546
    [No Abstract]   [Full Text] [Related]  

  • 6. INHIBITION OF PRUINE PHOSPHORIBOSYLTRANSFERASES OF EHRLICH ASCITES-TUMOUR CELLS BY 6-MERCAPTOPURINE.
    ATKINSON MR; MURRAY AW
    Biochem J; 1965 Jan; 94(1):64-70. PubMed ID: 14342250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE METABOLISM OF 9-ARABINOSYL-6-MERCAPTOPURINE IN NORMAL AND NEOPLASTIC TISSUES.
    KIMBALL AP; LEPAGE GA; BOWMAN B
    Can J Biochem; 1964 Dec; 42():1753-68. PubMed ID: 14241609
    [No Abstract]   [Full Text] [Related]  

  • 8. THE ROLE OF PI IN THE CONTROL OF GLYCOLYSIS IN ASCITES TUMOR CELLS.
    WU R
    Biochem Biophys Res Commun; 1965 Feb; 18():402-8. PubMed ID: 14300756
    [No Abstract]   [Full Text] [Related]  

  • 9. MECHANISM OF ACTION OF GLUCOSE AND PYRIMIDINE NUCLEOSIDES ON (14C)FORMATE UTILIZATION BY EHRLICH ASCITES CELLS.
    HERSCOVICS A; JOHNSTONE RM
    Biochim Biophys Acta; 1964 Nov; 91():365-73. PubMed ID: 14254007
    [No Abstract]   [Full Text] [Related]  

  • 10. BIOCHEMICAL MECHANISMS OF RESISTANCE TO ANTIMETABOLITES.
    PATERSON AR
    Proc Can Cancer Conf; 1963; 5():417-38. PubMed ID: 14278872
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance to 6-mercaptopurine. II. The synthesis of thioinosinate in a 6-mercaptopurine-resistant subline of the Ehrlich ascites carcinoma.
    PATERSON AR
    Can J Biochem Physiol; 1962 Feb; 40():195-206. PubMed ID: 14484318
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance to 6-mercaptopurine. I. Biochemical differences between the Ehrlich ascites carcinoma and a 6-mercaptopurine-resistant subline.
    PATERSON AR; HORI A
    Can J Biochem Physiol; 1962 Feb; 40():181-94. PubMed ID: 14484317
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to 6-mercaptopurine. III. Deletion of a 5'-nucleotidase in a 6-mercaptopurine-resistant subline of the Ehrlich ascites carcinoma.
    PATERSON AR; HORI A
    Can J Biochem Physiol; 1963 Jun; 41():1339-48. PubMed ID: 13941819
    [No Abstract]   [Full Text] [Related]  

  • 14. COMPARATIVE CLINICAL TOXICITY OF 6-MERCAPTOPURINE (NSC-755)-1 AND 6-MERCAPTOPURINE RIBONUCLEOSIDE (NSC-4911)-2 ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH ADVANCED CANCER.
    REGELSON W; HOLLAND JF; FREI E; GOLD GL; HALL T; KRANT M; MILLER SO
    Cancer Chemother Rep; 1964 Mar; 36():41-8. PubMed ID: 14152273
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of purine biosynthesis de novo and of Ehrlich ascites tumor cell growth by 6-methylmercaptopurine ribonucleoside.
    Shantz GD; Fontenelle LJ; Henderson JF
    Biochem Pharmacol; 1972 Apr; 21(8):1203-6. PubMed ID: 5034201
    [No Abstract]   [Full Text] [Related]  

  • 16. THE SYNTHESIS OF EXTRACELLULAR RIBONUCLEOSIDES BY ASCITES TUMOR CELLS IN VITRO.
    PATERSON AR
    Can J Biochem; 1965 Feb; 43():257-69. PubMed ID: 14325976
    [No Abstract]   [Full Text] [Related]  

  • 17. INHIBITION OF RIBONUCLEIC ACID AND DEOXYRIBONUCLEIC ACID SYNTHESIS IN EHRLICH ASCITES CELLS BY CORDYCEPIN-N1-OXIDE.
    FREDERIKSEN S
    Biochim Biophys Acta; 1963 Nov; 76():366-71. PubMed ID: 14097399
    [No Abstract]   [Full Text] [Related]  

  • 18. NUCLEOSIDE METABOLISM IN EHRLICH ASCITES TUMOR CELLS: PHOSPHOROLYSIS OF PURINE NUCLEOSIDES.
    GOTTO AM; MEIKLE AW; TOUSTER O
    Biochim Biophys Acta; 1964 Apr; 80():552-61. PubMed ID: 14156727
    [No Abstract]   [Full Text] [Related]  

  • 19. ACCUMULATION OF DEOXYADENOSINE PHOSPHATES IN ASCITES TUMOR CELLS UNDER DIFFERENT EXPERIMENTAL CONDITIONS.
    KLENOW H
    Acta Unio Int Contra Cancrum; 1964; 20():1021-2. PubMed ID: 14274683
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON THE EFFECT OF DESOXYRIBONUCLEOSIDES ON THE INCORPORATION OF RADIOACTIVE PHOSPHATE IN DNA-NUCLEOTIDES IN ASCITES TUMOR CELLS IN VITRO].
    LANGEN P; LISS E
    Biochem Z; 1963 Jul; 337():360-5. PubMed ID: 14046120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.